We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+9.19%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$709M
AUM Growth
-$77.6M
Cap. Flow
-$116M
Cap. Flow %
-16.41%
Top 10 Hldgs %
37.25%
Holding
452
New
12
Increased
91
Reduced
283
Closed
40

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$8.04M
2
AMAT icon
Applied Materials
AMAT
+$4.9M
3
APH icon
Amphenol
APH
+$4.75M
4
ANET icon
Arista Networks
ANET
+$4.46M
5
BABA icon
Alibaba
BABA
+$4.45M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$7.54M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$7.04M
3
ADBE icon
Adobe
ADBE
+$6.93M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$6.31M
5
GILD icon
Gilead Sciences
GILD
+$4.76M

Sector Composition

Rank Sector Weight
1 Technology 43.87%
2 Healthcare 22.25%
3 Consumer Discretionary 12.69%
4 Communication Services 10.44%
5 Consumer Staples 3.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DAWN
276
DELISTED
Day One Biopharmaceuticals
DAWN
$141K 0.02%
10,268
-6,549
-39% -$95.8K
VEEV icon
277
Veeva Systems
VEEV
$39.2B
$141K 0.02%
771
– –
DLTR icon
278
Dollar Tree
DLTR
$24.7B
$140K 0.02%
1,312
-1,409
-52% -$166K
XNCR icon
279
Xencor
XNCR
$1.72B
$137K 0.02%
7,243
-4,512
-38% -$96.9K
IRON icon
280
Disc Medicine
IRON
$3.09B
$131K 0.02%
2,904
-1,737
-37% -$59K
PRTA icon
281
Prothena Corp
PRTA
$475M
$130K 0.02%
6,318
-4,042
-39% -$87.5K
ELVN icon
282
Enliven Therapeutics
ELVN
$4.24B
$129K 0.02%
5,526
-2,426
-31% -$51.1K
FDMT icon
283
4D Molecular Therapeutics
FDMT
$621M
$127K 0.02%
6,073
-3,506
-37% -$88K
ARQT icon
284
Arcutis Biotherapeutics
ARQT
$3.3B
$126K 0.02%
13,601
-5,013
-27% -$45.3K
OCUL icon
285
Ocular Therapeutix
OCUL
$2.25B
$124K 0.02%
18,196
-3,003
-14% -$18.5K
SDGR icon
286
Schrodinger
SDGR
$1.39B
$124K 0.02%
6,410
– –
GMAB icon
287
Genmab
GMAB
$19.6B
$124K 0.02%
4,927
-3,097
-39% -$87.8K
COLL icon
288
Collegium Pharmaceutical
COLL
$834M
$124K 0.02%
3,844
-2,276
-37% -$78.9K
IRWD icon
289
Ironwood Pharmaceuticals
IRWD
$714M
$122K 0.02%
18,676
-11,415
-38% -$80.7K
TARS icon
290
Tarsus Pharmaceuticals
TARS
$3.07B
$121K 0.02%
4,438
-2,129
-32% -$71.6K
INVA icon
291
Innoviva
INVA
$1.5B
$120K 0.02%
7,335
-4,837
-40% -$75K
CGEM icon
292
Cullinan Oncology
CGEM
$1.26B
$118K 0.02%
6,771
-2,225
-25% -$47.4K
ARM icon
293
Arm
ARM
$290B
$116K 0.02%
+711
New +$88.4K
MRVI icon
294
Maravai LifeSciences
MRVI
$861M
$112K 0.02%
15,604
-9,830
-39% -$84.9K
MDB icon
295
MongoDB
MDB
$35.2B
$110K 0.02%
441
+115
+35% +$36.3K
TJX icon
296
TJX Companies
TJX
$169B
$110K 0.02%
1,000
– –
WBD icon
297
Warner Bros
WBD
$69.3B
$110K 0.02%
14,732
+3,728
+34% +$29.9K
TNGX icon
298
Tango Therapeutics
TNGX
$4.31B
$108K 0.02%
12,552
-7,017
-36% -$54.2K
ZLAB icon
299
Zai Lab
ZLAB
$2.86B
$105K 0.01%
6,045
-3,485
-37% -$61.3K
ABCL icon
300
AbCellera Biologics
ABCL
$3.18B
$102K 0.01%
34,546
-21,760
-39% -$82.3K
10 11
12
13 14

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q2 2024 Portfolio in Review

As of Q2 2024, China Universal Asset Management Company held 452 positions worth $709M, down 9.9% from $787M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

China Universal Asset Management Company withdrew a net $116M in Q2 2024, closing 40 positions and reducing 283 holdings. Its most notable exit was Super Micro Computer, an estimated $4.04M position sold in full.

By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 37% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, China Universal Asset Management Company opened a new position in Arista Networks worth $5.26M.

  • China Universal Asset Management Company's largest Q2 2024 buy was Arista Networks: 60,000 shares worth $5.26M.
  • China Universal Asset Management Company added most to Apple in Q2 2024, an estimated $8.04M increase.
  • China Universal Asset Management Company's biggest Q2 2024 reduction was Amgen, cutting an estimated $7.54M.
  • China Universal Asset Management Company fully exited Super Micro Computer in Q2 2024, selling an estimated $4.04M.
  • China Universal Asset Management Company's ten largest holdings make up 37% of its $709M portfolio in Q2 2024.
  • China Universal Asset Management Company opened 12 new positions and closed 40 in Q2 2024.
  • China Universal Asset Management Company's portfolio value fell 9.9% quarter-over-quarter to $709M.

Based on China Universal Asset Management Company's 13F filing for Q2 2024, filed 19 Jul 2024.